Stock Split History
ETFs Holding RCEL »    RCEL Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AVITA Medical and its subsidiaries, including AVITA Medical Pty Limited, is a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Co.'s patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Co.'s RECELL® Autologous Cell Harvesting System enables clinicians to prepare Spray-On Skin™ Cells, an autologous skin cell suspension that is sprayed onto the patient to regenerate skin. According to our AVITA Medical stock split history records, AVITA Medical has had 1 split.
AVITA Medical stock split history picture
AVITA Medical (RCEL) has 1 split in our AVITA Medical stock split history database. The split for RCEL took place on June 30, 2020. This was a 1 for 5 reverse split, meaning for each 5 shares of RCEL owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 200 share position following the split.

When a company such as AVITA Medical conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the AVITA Medical stock split history from start to finish, an original position size of 1000 shares would have turned into 200 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into AVITA Medical shares, starting with a $10,000 purchase of RCEL, presented on a split-history-adjusted basis factoring in the complete AVITA Medical stock split history. AVITA Medical split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 09/26/2012
End date: 09/23/2022
Start price/share: $13.00
End price/share: $5.36
Dividends collected/share: $0.00
Total return: -58.77%
Average Annual Total Return: -8.48%
Starting investment: $10,000.00
Ending investment: $4,123.50
Years: 10.00
Date Ratio
06/30/20201 for 5
RCEL is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

RCKT Split History
RCPI Split History
RDNT Split History
RDY Split History
REPH Split History
RGLS Split History
RHE Split History
RMD Split History
RMED Split History
RMTI Split History

Also explore: RCEL shares outstanding history

Email EnvelopeFree RCEL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Annaly Capital Management, Inc. (NLY)
CohBar, Inc. (CWBR)
TOP Ships Inc. (TOPS)
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Nabriva Therapeutics plc (NBRV)
NeuroBo Pharmaceuticals, Inc. (NRBO)
First Wave BioPharma, Inc. (FWBI)
Palatin Technologies, Inc. (PTIN)
TD Holdings, Inc. (GLG )
Iterum Therapeutics plc (ITRM)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding AVITA Medical
AVITA Medical Insider Buying

AVITA Medical Stock Split History | | Copyright © 2013 - 2022, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.